Document is current
Any future updates will be listed below
-
Authors
Chaudhry, Farhan https://orcid.org/0000-0003-0951-7279
Lavandero, Sergio
Xie, Xiang https://orcid.org/0000-0002-0632-4626
Sabharwal, Basera
Zheng, Ying-Ying
Correa, Ashish
Narula, Jagat
Levy, Phillip
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04312009 at ClinicalTrials.govnct04311177 at ClinicalTrials.govDocuments that mention this clinical trial
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
https://doi.org/10.2215/cjn.03530320
COVID-19 and its impact on the cardiovascular system
https://doi.org/10.1136/openhrt-2020-001472
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis
https://doi.org/10.1136/thoraxjnl-2020-215768
Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection
https://doi.org/10.34067/kid.0003792020
Beware of simple explanations
https://doi.org/10.1136/heartjnl-2020-317605
Manipulation of ACE2 expression in COVID-19
https://doi.org/10.1136/openhrt-2020-001424
nct04287686 at ClinicalTrials.govDocuments that mention this clinical trial
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
https://doi.org/10.2215/cjn.03530320
Beware of simple explanations
https://doi.org/10.1136/heartjnl-2020-317605
Manipulation of ACE2 expression in COVID-19
https://doi.org/10.1136/openhrt-2020-001424
Documents that mention this clinical trial
ACE2 and COVID-19 and the resulting ARDS
https://doi.org/10.1136/postgradmedj-2020-137935
Manipulation of ACE2 expression in COVID-19
https://doi.org/10.1136/openhrt-2020-001424
-
Funding
Funding for this research was provided by:
Agencia Nacional de Investigacion y Desarrollo (Chile: FONDAP 15130011)
- License Information
